Cardinal Health, Inc. (CAH)

$103.21

-0.6

(-0.58%)▲

Market is closed - opens 7 PM, 29 Apr 2024

Insights on Cardinal Health, Inc.

  • Increasing Revenue

    Revenue is up for the last 4 quarters, 50.48B → 57.44B (in $), with an average increase of 4.2% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -64.0M → 353.0M (in $), with an average increase of 739.3% per quarter

  • Vs MCK

    In the last 1 year, Mckesson Corporation has given 50.3% return, outperforming this stock by 21.2%

  • Vs MCK

    In the last 3 years, Mckesson Corporation has given 181.8% return, outperforming this stock by 110.2%

Performance

  • $102.93
    $103.85
    $103.21
    downward going graph

    0.27%

    Downside

    Day's Volatility :0.88%

    Upside

    0.61%

    downward going graph
  • $75.98
    $115.52
    $103.21
    downward going graph

    26.38%

    Downside

    52 Weeks Volatility :34.23%

    Upside

    10.66%

    downward going graph

Returns

PeriodCardinal Health, Inc.Sector (Health Care)S&P500
3 Months
-1.79%
0.5%
3.2%
6 Months
12.17%
11.7%
22.0%
1 Year
29.13%
6.2%
24.5%
3 Years
71.64%
13.5%
20.6%

Highlights

Market Capitalization
25.2B
Book Value
- $14.13
Dividend Share
1.998
Dividend Yield
1.93%
Earnings Per Share (EPS)
2.52
PE Ratio
41.09
PEG Ratio
0.31
Wall Street Target Price
115.21
Profit Margin
0.3%
Operating Margin TTM
0.87%
Return On Assets TTM
2.79%
Return On Equity TTM
0.0%
Revenue TTM
216.1B
Revenue Per Share TTM
859.44
Quarterly Revenue Growth YOY
11.600000000000001%
Gross Profit TTM
6.5B
EBITDA
2.7B
Diluted Eps TTM
2.52
Quarterly Earnings Growth YOY
-0.95
EPS Estimate Current Year
7.29
EPS Estimate Next Year
7.89
EPS Estimate Current Quarter
1.6
EPS Estimate Next Quarter
1.9

Analyst Recommendation

Hold
    36%Buy
    63%Hold
    0
    0%Sell
Based on 19 Wall street analysts offering stock ratings for Cardinal Health, Inc.(by analysts ranked 0 to 5 stars)
Based on 19 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
12
12
14
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 11.63%

Current $103.21
Target $115.21

Company Financials

FY18Y/Y Change
Revenue
136.8B
↑ 5.26%
Net Income
256.0M
↓ 80.12%
Net Profit Margin
0.19%
↓ 0.8%
FY19Y/Y Change
Revenue
145.5B
↑ 6.38%
Net Income
1.4B
↑ 432.42%
Net Profit Margin
0.94%
↑ 0.75%
FY20Y/Y Change
Revenue
152.9B
↑ 5.08%
Net Income
-3.7B
↓ 370.95%
Net Profit Margin
-2.41%
↓ 3.35%
FY21Y/Y Change
Revenue
162.5B
↑ 6.24%
Net Income
611.0M
↓ 116.54%
Net Profit Margin
0.38%
↑ 2.79%
FY22Y/Y Change
Revenue
181.4B
↑ 11.63%
Net Income
-932.0M
↓ 252.54%
Net Profit Margin
-0.51%
↓ 0.89%
FY23Y/Y Change
Revenue
205.0B
↑ 13.04%
Net Income
261.0M
↓ 128.0%
Net Profit Margin
0.13%
↑ 0.64%
Q3 FY22Q/Q Change
Revenue
49.6B
↑ 5.31%
Net Income
110.0M
↓ 20.29%
Net Profit Margin
0.22%
↓ 0.07%
Q4 FY22Q/Q Change
Revenue
51.5B
↑ 3.76%
Net Income
-130.0M
↓ 218.18%
Net Profit Margin
-0.25%
↓ 0.47%
Q1 FY23Q/Q Change
Revenue
50.5B
↓ 1.91%
Net Income
345.0M
↓ 365.38%
Net Profit Margin
0.68%
↑ 0.93%
Q2 FY23Q/Q Change
Revenue
53.5B
↑ 5.87%
Net Income
-64.0M
↓ 118.55%
Net Profit Margin
-0.12%
↓ 0.8%
Q3 FY23Q/Q Change
Revenue
54.8B
↑ 2.45%
Net Income
5.0M
↓ 107.81%
Net Profit Margin
0.01%
↑ 0.13%
Q4 FY23Q/Q Change
Revenue
57.4B
↑ 4.9%
Net Income
353.0M
↑ 6960.0%
Net Profit Margin
0.61%
↑ 0.6%
FY18Y/Y Change
Total Assets
40.0B
↓ 0.4%
Total Liabilities
33.9B
↑ 1.83%
FY19Y/Y Change
Total Assets
41.0B
↑ 2.53%
Total Liabilities
34.6B
↑ 2.19%
FY20Y/Y Change
Total Assets
40.8B
↓ 0.48%
Total Liabilities
39.0B
↑ 12.53%
FY21Y/Y Change
Total Assets
44.5B
↑ 9.04%
Total Liabilities
42.7B
↑ 9.46%
FY22Y/Y Change
Total Assets
43.9B
↓ 1.29%
Total Liabilities
44.6B
↑ 4.51%
FY23Y/Y Change
Total Assets
43.4B
↓ 1.05%
Total Liabilities
46.3B
↑ 3.78%
Q3 FY22Q/Q Change
Total Assets
43.4B
↓ 1.12%
Total Liabilities
45.2B
↑ 1.31%
Q4 FY22Q/Q Change
Total Assets
44.5B
↑ 2.52%
Total Liabilities
46.7B
↑ 3.38%
Q1 FY23Q/Q Change
Total Assets
43.4B
↓ 2.48%
Total Liabilities
45.6B
↓ 2.35%
Q2 FY23Q/Q Change
Total Assets
43.4B
↑ 0.09%
Total Liabilities
46.3B
↑ 1.48%
Q3 FY23Q/Q Change
Total Assets
43.7B
↑ 0.67%
Total Liabilities
47.2B
↑ 2.01%
Q4 FY23Q/Q Change
Total Assets
46.6B
↑ 6.55%
Total Liabilities
50.0B
↑ 5.97%
FY18Y/Y Change
Operating Cash Flow
2.8B
↑ 133.78%
Investing Cash Flow
-5.6B
↑ 1284.69%
Financing Cash Flow
-2.3B
↓ 160.76%
FY19Y/Y Change
Operating Cash Flow
2.7B
↓ 1.66%
Investing Cash Flow
338.0M
↓ 106.03%
Financing Cash Flow
-2.3B
↑ 0.75%
FY20Y/Y Change
Operating Cash Flow
2.0B
↓ 27.99%
Investing Cash Flow
493.0M
↑ 45.86%
Financing Cash Flow
-2.2B
↓ 4.06%
FY21Y/Y Change
Operating Cash Flow
2.4B
↑ 23.93%
Investing Cash Flow
-378.0M
↓ 176.67%
Financing Cash Flow
-1.3B
↓ 40.14%
FY22Y/Y Change
Operating Cash Flow
3.1B
↑ 28.53%
Investing Cash Flow
567.0M
↓ 250.0%
Financing Cash Flow
-2.5B
↑ 87.02%
FY23Y/Y Change
Operating Cash Flow
2.8B
↓ 9.06%
Investing Cash Flow
-454.0M
↓ 180.07%
Financing Cash Flow
-3.1B
↑ 23.87%
Q3 FY22Q/Q Change
Operating Cash Flow
23.0M
↓ 99.23%
Investing Cash Flow
-70.0M
↓ 65.69%
Financing Cash Flow
-1.2B
↑ 180.24%
Q4 FY22Q/Q Change
Operating Cash Flow
597.0M
↑ 2495.65%
Investing Cash Flow
-87.0M
↑ 24.29%
Financing Cash Flow
-362.0M
↓ 68.87%
Q1 FY23Q/Q Change
Operating Cash Flow
1.4B
↑ 127.97%
Investing Cash Flow
-91.0M
↑ 4.6%
Financing Cash Flow
-934.0M
↑ 158.01%
Q2 FY23Q/Q Change
Operating Cash Flow
858.0M
↓ 36.96%
Investing Cash Flow
-206.0M
↑ 126.37%
Financing Cash Flow
-592.0M
↓ 36.62%
Q3 FY23Q/Q Change
Operating Cash Flow
545.0M
↓ 36.48%
Investing Cash Flow
-63.0M
↓ 69.42%
Financing Cash Flow
-666.0M
↑ 12.5%

Technicals Summary

Sell

Neutral

Buy

Cardinal Health, Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cardinal Health, Inc.
Cardinal Health, Inc.
-6.98%
12.17%
29.13%
71.64%
118.5%
Cencora Inc
Cencora Inc
-1.25%
27.13%
34.02%
91.03%
118.98%
Mckesson Corporation
Mckesson Corporation
0.72%
19.55%
50.3%
181.78%
359.21%
Henry Schein, Inc.
Henry Schein, Inc.
-0.08%
9.49%
-10.33%
-0.76%
12.95%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cardinal Health, Inc.
Cardinal Health, Inc.
41.09
41.09
0.31
7.29
0.0
0.03
0.02
-14.13
Cencora Inc
Cencora Inc
23.39
23.39
1.58
11.93
2.34
0.03
0.01
3.39
Mckesson Corporation
Mckesson Corporation
24.22
24.22
4.96
27.6
0.0
0.04
0.0
-15.62
Henry Schein, Inc.
Henry Schein, Inc.
23.17
23.17
1.65
5.07
0.09
0.05
NA
28.28
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cardinal Health, Inc.
Cardinal Health, Inc.
Hold
$25.2B
118.5%
41.09
0.3%
Cencora Inc
Cencora Inc
Buy
$38.5B
118.98%
23.39
0.66%
Mckesson Corporation
Mckesson Corporation
Buy
$70.4B
359.21%
24.22
0.99%
Henry Schein, Inc.
Henry Schein, Inc.
Hold
$9.4B
12.95%
23.17
3.37%

Institutional Holdings

  • Vanguard Group Inc

    12.85%

  • BlackRock Inc

    10.73%

  • State Street Corporation

    5.97%

  • Geode Capital Management, LLC

    2.24%

  • FMR Inc

    2.22%

  • Arrowstreet Capital Limited Partnership

    1.93%

Corporate Announcements

  • Cardinal Health, Inc. Dividends March,2024

    In the quarter ending March,2024. Cardinal Health, Inc. has declared dividend of $0.5

    Read More

Company Information

cardinal health, inc. (nyse: cah), is a global integrated healthcare services and products company, providing customized solutions for hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. the company provides clinically-proven medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. cardinal health connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management. backed by nearly 100 years of experience, with more than 37,000 employees in nearly 60 countries, cardinal health ranks among the top 25 on the fortune 500. for more information, visit cardinalhealth.com, follow @cardinalhealth on twitter.

Organization
Cardinal Health, Inc.
Employees
47040
CEO
Mr. Jason M. Hollar
Industry
Wholesale Trade

Discover More

FAQs